It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
At present, there is a lack of well-validated protocols that allow for the analysis of the mechanical properties of muscle and tendon tissues. Further, there are no reports regarding characterization of mouse skeletal muscle and tendon mechanical properties in vivo using elastography thereby limiting the ability to monitor changes in these tissues during disease progression or response to therapy. Therefore, we sought to develop novel protocols for the characterization of mechanical properties in musculotendinous tissues using atomic force microscopy (AFM) and ultrasound elastography. Given that TIEG1 knockout (KO) mice exhibit well characterized defects in the mechanical properties of skeletal muscle and tendon tissue, we have chosen to use this model system in the present study. Using TIEG1 knockout and wild-type mice, we have devised an AFM protocol that does not rely on the use of glue or chemical agents for muscle and tendon fiber immobilization during acquisition of transversal cartographies of elasticity and topography. Additionally, since AFM cannot be employed on live animals, we have also developed an ultrasound elastography protocol using a new linear transducer, SLH20-6 (resolution: 38 µm, footprint: 2.38 cm), to characterize the musculotendinous system in vivo. This protocol allows for the identification of changes in muscle and tendon elasticities. Such innovative technological approaches have no equivalent to date, promise to accelerate our understanding of musculotendinous mechanical properties and have numerous research and clinical applications.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Biomechanics and Bioengineering Laboratory, UMR CNRS 7338, Alliance Sorbonne Universités, Université de Technologie de Compiègne, Compiègne, France
2 CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, Université Lille, F-59000, Lille, France (GRID:grid.410463.4) (ISNI:0000 0004 0471 8845)
3 Biomechanics and Bioengineering Laboratory, UMR CNRS 7338, Alliance Sorbonne Universités, Université de Technologie de Compiègne, Compiègne, France (GRID:grid.410463.4)
4 Centre de Biophysique Moléculaire, CNRS UPR4301, Orléans, France (GRID:grid.417870.d) (ISNI:0000 0004 0614 8532)
5 Laboratoire de Réactivité de Surface UMR 7197, Sorbonne Université, Paris, France (GRID:grid.503342.3) (ISNI:0000 0004 0369 9793)
6 EA Chimère 7516 UPJV, CHU Amiens Imagerie Médicale, Institut Faire Faces, Amiens, France (GRID:grid.503342.3)
7 Mayo Clinic, Department of Biochemistry and Molecular Biology, Rochester, USA (GRID:grid.66875.3a) (ISNI:0000 0004 0459 167X)
8 Biomechanics and Bioengineering Laboratory, UMR CNRS 7338, Alliance Sorbonne Universités, Université de Technologie de Compiègne, Compiègne, France (GRID:grid.66875.3a)